BACTERIA STRAIN LACTOBACILLUS ACIDOPHILUS N.V. EP 317/402 NARINE AAA USED IN THE PRODUCTION OF PREPARATIONS AND OF DIETETIC, THERAPEUTIC AND PROPHYLACTIC PRODUCTS FOR TREATING DYSBACTERIOSIS AND THE CONSEQUENCES THEREOF

摘要

The present invention pertains to the field of biotechnology and may be used in the dairy industry as well as in medicine and in veterinary medicine. This invention essentially relates to the bacteria strain Lactobacillus acidophilus n.v. EP 317/402 "Narine" AAA which is obtained by collecting the same from a starting culture of Lactobacillus acidophilus n.v. EP 317/402 "Narine" and using a selection process that takes into account the antagonistic activity relative to the intestine microflora, the resistance to antibiotics having a large action range and the multiplication dynamics of the bacterial population in a nutritive medium. The strain Lactobacillus acidophilus n.v. EP 317/402 "Narine" AAA has been recorded at the Russian national collection of industrial micro-organism under the number B-7747 as well as at the Collection micro-organism cultures GNTs "Vector" under the number B-741. The increased resistance of this strain to antibiotics allows for its use in bacteriological and antibiotic therapy where it has an increased sanitising and prophylactic effect. The product "Marine" is produced in the form of a dry ferment and can be used as a drug agent for treating and preventing dysbacteriosis as well as the consequences thereof, including secondary immunodeficiency.